Cantanhede biotechnology team will start testing a new vaccine

in News · 26-09-2020 16:00:00 · 0 Comments

A biotechnology company, based in the Technology Park of Cantanhede will start tests in mice to develop a vaccine for Covid-19.

According to Lusa, within two to three months, they should have “results that allow us to start testing on humans”. The vaccine production, when approved, will be done with a company in Canada.

“The knowledge generated in the vaccine development process has allowed us to move quickly towards trials to develop a vaccine for covid-19,” said the CEO of Immunethep, Bruno Santos

“The vaccine has a dual function: to induce the production of specific antibodies to neutralize SARS-CoV-2 and increase our natural ability to fight viral infections”, reads the document issued by the company.


Be the first to comment on this article
Interactive Topics, send us your comments/opinion on this article.

Please note that The Portugal News may use selected comments in the printed edition of the newspaper.